AAOMS Annual Meeting

<p>The U.S. Food and Drug Administration changed the rules governing how prescription drugs and biologics used during pregnancy and breastfeeding are labeled.</p>

By Reuters Staff

The FDA has approved a new opioid that features specific properties designed to deter, but not prevent, abuse.

The FDA has approved a new opioid that features specific properties designed to deter, but not prevent, abuse.

The FDA has approved a new opioid that features specific properties designed to deter, but not prevent, abuse.

The FDA has approved a new option for patients with relapsing multiple sclerosis and inadequate response to other treatment options.

The FDA has approved a new once-daily combination drug for the treatment of type 2 diabetes.

Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with meningitis B, hemophilia A, and non-valvular atrial fibrillation.

Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with meningitis B, hemophilia A, and non-valvular atrial fibrillation.

Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with meningitis B, hemophilia A, and non-valvular atrial fibrillation.